The effect of drugs for Alzheimer disease assessed by means of neuroradiological techniques

Current Medicinal Chemistry

Volumn 13, Issue 28, 2006, Pages 3417-3424

  Modrego, Pedro J ^a  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

Alzheimer's disease; Effect of drugs; Neuroradiologic techniques

Indexed keywords

CHOLINE DERIVATIVE; CHOLINESTERASE; DONEPEZIL; DRUG METABOLITE; FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE; GALANTAMINE; MEMANTINE; MILAMELINE; N ACETYLASPARTIC ACID; PLACEBO; RIVASTIGMINE; XANOMELINE;

ALZHEIMER DISEASE; BRAIN ATROPHY; BRAIN METABOLISM; CELL DAMAGE; CELL MEMBRANE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DISEASE COURSE; DRUG BRAIN LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG MONITORING; DRUG RESPONSE; DRUG STRUCTURE; EMBASE; ENZYME INHIBITION; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; MEDLINE; META ANALYSIS; NEUROIMAGING; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PROTEIN DETERMINATION; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SINGLE DRUG DOSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMATIC REVIEW; VOLUMETRY;

ALZHEIMER DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; NOOTROPIC AGENTS;

EID: 33845328003     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986706779010289     Document Type: Review

References (58)

1. Francis, P.T.; Palmer, A.M.; Snape, M.; Wilcock, G.K. J. Neurol. Neurosurg. Psychiatry, 1999, 66, 137-147.
2. Whitehouse, P.J.; Price, D.L.; Clark, A.W.; Coyle, J.T.; DeLong, M.R. Ann. Neurol., 1981, 10, 122-126.
3. Sasaki, H.; Muramoto, O.; Kanazawa, I.; Arai, H.; Kosaka, K.; Iizuka, R. Ann. Neurol., 1986, 19, 263-269.
4. Lane, R.M.; Potkin, S.G.; Enz., A. Int. J. Neuropsychopharmacol., 2006, 9, 101-124.
5. Ritchie, C.W.; Ames, D.; Clayton, T.; Lai, R. Am. J. Geriatr. Psychiatry, 2004, 12, 358-369.
6. Cummings, J.L. New. Engl. J. Med., 2004, 351, 56-67,
7. Choi, D.W.; Koh, J.Y.; Peters, S. J. Neurosci., 1988, 8, 185-196.
8. Choi, D.W. J. Neurobiol., 1992, 23, 1261-1276.
9. Parsons, C.G.; Danysz, W.; Quack, G. Neuropharmacology, 1999, 38, 735-767.
10. Areosa, S.A.; Sherriff, F.; McShane, R. Cochrane Database Syst. Rev., 2005, 20, CD003154.
11. De Leon, M. An atlas of Alzheimer's disease, The Parthenon Publisbing Group Inc: New York, 1999.
12. Alexander, G.E.; Chen, K.; Pietrini, P.; Rapoport, S.I.; Reiman, E.M. Am. J. Psychiatry, 2002, 159, 738-745.
13. Salmon, E.; Lespagnard, S.; Marique, P.; Peeters, F.; Herholz, K.; Perani, D.; Holthoff, V.; Kalbe, E.; Aachisi, D.; Adam, S.; Collette, F.; Garraux, G. J. Neurol., 2005, 252, 283-290.
14. Holthoff, V.A.; Beuthien-Baumann, B.; Kalbe, E.; Ludecke, S.; Lenz, O.; Zundorf, G.; Spirling, S.; Schierz, K.; Winiecki, P.; Sorbi, S.; Herholz, K. Biol. Psychiatry, 2005, 57, 412-421.
15. Anchisi, D.; Borroni B.; Franceschi, M,; Kerrouche, N.; Kalbe, E.; Beuthien-Beumann, B.; Capps, S.; Lenz, O.; Ludecke, S.; Marcone, A.; Mielke, R.; Ortelli, P.; Padovani, A.; Pelati, O.; Pipi A.; Scarpini, E.; Weisenbach, S.; Herholz, K.; Salmon, E.; Holthoff V.; Sorbi, S.; Fazio, F.; Perani D. Arch. Neurol., 2005. 62, 1728-1733.
16. Bohnen, N.I.; Kaufer, D.I.; Hendrickson, R.; Ivanco, L.S.; Lopresti, B.J.; Davis, J.G.; Constantine, G.; Mathis, C.A.; Moore, R.Y.; DeKosky, S.T. Neurosci. Lett., 2005, 380, 127-132.
17. Kuhl, D.E.; Koeppe, R.A.; Snyder, S.E.; Minoshima, S. Frey, K.A.; Kilbourn, M.R. Anm. Neurol., 2006, 59, 13-20.
18. Bloch, F. Phys. Rev., 1946, 70, 460-474.
19. Purcell, E.U.; Torrey, H.C.; Pound, R.V. Phys. Rev., 1946, 69, 37-39.
20. Golomb, J.; de Leon, M.J.; Kluger, A.; George, A.E.;, Tarshish, C.; Ferris, S.H. Arch. Neurol., 1993, 50, 967-973.
21. Convit, A.; de Leon, M.J.; Golomb, J.; George, A.E.; Tarshish, C.Y.; Bobinski, M.; Tsui, W.; De Santis, S.; Wegiel, J.; Wisniewscki, H. Psychiatr. Q., 1993, 64, 371-391.
22. Erkinjuntti, T.; Lee, D.H.; Gao, F.; Steenhuis, R.; Eliasziw, M.; Fry, R.; Merskey, H.; Hachinski, V.C Arch. Neurol., 1993, 50, 305-310.
23. Petersen, R.C.; Jack, C.R.; Xu, Y.C.; Waring, S.C.; O'Brien, P.C.; Smith, G.E.; Ivnik, R.J.; Tangalos, E.G.; Boeve, B.F.; Kokmen, E. Neurology, 2000, 54, 581-587.
24. Jack C.R.; Petersen, R.C.; Xu, Y.; O'Brien, P.C.; Smith, G.E.; Ivnik, R.J.; Boeve, B.F.; Tangalos, E.G.; Kokmeh, E. Neurology, 2000, 55, 484-490.
25. Kantarci K, Jack, C.R. NeuroRx, 2004, 1, 196-205.
26. Jack. C.R.; Wengenack T.M.; Reyes, D.A.; Garwood, M.; Curran, G.L.; Borowski, B.J.; Lin, J.; Preboske, G.M.; Holasek, S.S.; Adriany, G.; Poduslo, J.F. J. Neurosci., 2005, 25, 10041-10048.
27. Poduslo, J.F. Wengenack TM, Curran GL,Wisniewski, T.; Sigurdsson, E.M.; Macura, S.I.; Borowski, B.J.; Jack, C.R. Neurobiol. Dis., 2002, 11, 315-329.
28. Maheshwari, S.; Fatterpeaker, G.; Castillo, M.; Mukherji, S.K. Semin. Utrasound CT. MR., 2000, 21(6), 434-451.
29. Bonavita, S.; Di Salle, F.; Tedeschi, G. Eur. J. Radiol., 1999, 30, 125-131.
30. Valenzuela M.J.; Sachdev, P. Neurology, 2001, 56, 592-598.
31. Jung, R.E.; Yeo, R.A.; Chiulli, S.J.; Sibbitt, W.L.; Brooks, W.M. Neuroreport, 2000, 10, 3327-3331.
32. Ross, B.; Bluml, S.; Cowan, R.; Danielsen, E.; Farrow, N.; Gruetter, R. Biophys. Chem, 1997, 687, 161-172.
33. Pfefferbaum, A.; Adalsteinsson, E.; Spielman, D.; Sullinavan, E.; Lim, K. Arch. Gen. Psychiatry, 1999, 56, 185-192
34. Meyerhoff, D.; MacKay, S.; Constans, J.; Norman, D.; Van Dyke, C.; Fein, G.; Weiner, M.W. Ann. Neurol., 1994. 36, 40-47.
35. Kantarci, K.; Petersen, R.C.; Boeve, B.F.; Knopman D.; Tang-Wai, D.F.; O'Brien, P.C.; Weigand, S.D.; Edland, S.D.; Smith, G.E.; Ivnik, R.J.; Ferman, T.J.; Tangalos, E.G.; Jack, C.R. Neurology, 2004, 63, 1393-1398.
36. Modrego P.J.; Fayed, N.; Pina, M.A. Am. J. Psychiatry, 2005, 162, 667-675.
37. Metastasio A.; Rinaldi, P.; Tarducci, R.; Mariani E.; Feliziani, F.T.; Cherubini, A.; Pelliccioli, G.P.; Gobbi G.; Senin, U.; Mecocci, P. Neurobiol. Aging, 2006, 27, 926-932.
38. Marjanska, M.; Curran G.L.; Wengenack, T.M.; Henry, P.G.; Bliss, R.L.; Poduslo, J.F.; Jack, C.R.; Ugurbil, K.; Garwood, M. Proc. Natl. Acad. Sci. USA, 2005, 102, 11906-11910.
39. Satlin, A.; Bodick, N.; Offen, W.; Renshaw, P. Am. J. Psychiatry, 1997, 154, 1459-1461.
40. Frederick, B.; Satlin, A.; Wald, L.L.; Hennen, J.; Bodick, N.; Renshaw, P.F. Am. J. Geriatr. Psychiatry, 2002, 10, 81-88.
41. Mega, M.S.; Dinov, I.D.; Lee, L; O'Connor, S.M.; Masterman, D.M.; Wilen, B.; Mishkin, F.; Toga, A.W.; Cummings, J.L. J. Neuropsychiatry Clin. Neurosci., 2000, 12, 209-218.
42. Potkin, S.G.; Anand, R.; Fleming, K.; Alva, G.; Keator, D.; Carreon, D.; Messina, J.; Wu, J.C.; Hartman, R.; Fallon, J.H. Int. J. Neuropsychopharmacol., 2001, 4, 223-230.
43. Kombouts, S.A.; Barkhof, F.; Van Meel, C.S.; Scheltens, P. J. Neurol. Neurosurg. Psychiatry, 2002, 73, 665-671.
44. Kaasinen, V.; Nagren, K.; Jarvenpaa T.; Roivainen, A.; Yu, M.; Oikonen-Kurki, T.; Rinne, J.O. J. Clin. Psychopharmacol., 2002, 22, 615-620,
45. Nobili F.; Koulibaly, M.; Vitali, P.; Migneco, O.; Mariani, G.; Ebmeier, K.; Pupi, A.; Robert, P.H.; Rodriguez, G.; Darcourt J. J. Nucl. Mod, 2002, 43, 983-990.
46. Jack, C.R.; Slomkowski, M.; Gracon, S.; Hoover, T.M.; Felmlee, J.P.; Srewart K.; Xu Y.; Shiung, M.; O'Brien, P.C.; Cha, R.; Knopman, D.; Petersen, R.C. Neurology, 2003, 60, 253-260.
47. Krishnan, K.; Charles, H.C.; Doraiswamy, P.M.; Mintzer, J.; Weiler, R.; Yu, X.; Perdomo, C.; Ieni, J.; Rogers, S. Am. J. Psychiatry, 2003, 160, 2003-2011,
48. Potkin, S.G.; Alva, G.; McDonald, S.; Gergel, I.; Keator, D.; Fallon, L.Hl. Memantine monotherapy increases brain metabolism (PET) and effectively treats mild to moderate Alzheimer's disease. 129th meeting of the American Neurological Association. Toronto, Canada. October 3-6, 2004.
49. Bohnen, N.I.; Kaufer, D.I.; Hendrickson, R.; Ivanco, L.S.; Lopressti, B.J.; Koeppe, R.A.; Meltzer, C.C.; Constantine, G.; Davis, J.G.; Mathis, C.A.; Dekosky, S.T.; Moore, R.Y. J. Neurol. Neurosurg. Psychiatry, 2005, 76, 315-319.
50. Kircher, T., Erb, M.; Grodd, W.; Leube, D.T. Am. J. Geriatr. Psychiatry, 2005, 13, 1006-1013.
51. Hashimoto, M.; Kazui, H.; Nakano.; Y, Yasuda, M.; Mori, E. Am. J. Psychiatry, 2005, 162, 676-682.
52. Mega, M.S.; Dinov, I.D.; Porter, V.; Chow, G.; Reback, E.; Davoodi, P.; O'Connor, S.M.; Carter, M.F.; Amezcua, H.; Cummings, J.L,. Arch. Neurol., 2005, 62, 721-728.
53. Stefanova, E.; Wall A.; Almkvist, O.; Nilsson, A.; Forsberg, A.; Langstrom, B.; Nordberg, A. J. Neural. Transm., 2006, 113, 205-218.
54. Modrego, P.J.; Pina, M.A.; Fayed, N.; Díaz, M. CNS Drugs, 2006; (in press).
55. Shoghi-Jadid, K.; Small, G.W.; Agdeppa, E.D.; Kepe, V.; Ercoli, L.M.; Siddarth, P.; Read, S.; Satyamurthy N.; Petric, A.; Huang, S.C.; Barrio, J.R. Am. J. Geriatr. Psychiatry, 2002, 10, 24-34.
56. Bacskai, B.J.; Hickey, G.A.; Skoch, J.; Kajdasz, S.T.; Wang, Y.; Huang, G.F.; Mathis, C.A.; Klunk, W.E.; Hyman, B.T. Proc. Natl. Acad Sci. USA, 2003, 100, 12462-12467.
57. Price, J.C.; Klunk, W.E.; Lopresti, B.J.; Lu, X.; Hoge, J.A.; Ziolko, S.K.; Holt, D.P.; Meltzer, C.C.; DEKosky, S.T.; Mathis, C.A. J. Cereb. Blood Flow Metab., 2005, 25, 1528-1547,
58. Arriagada, P.V.; Growdon, J.H.; Hedley-Whyte, E.T.; Hymann, B.T. Neurology, 1992, 42, 631-639.